United States  

Gilead Sciences' remdesivir could get US emergency approval for coronavirus treatment

Proactive Investors Thursday, 30 April 2020
Gilead Sciences Inc’s (NASDAQ:GILD) antiviral candidate remdesivir is reportedly getting emergency-use authorisation by the US Food and Drug Administration (FDA). The thumbs-up could come as soon as Wednesday, The New York Times reported. READ: Gilead Sciences posts positive data on coronavirus treatment trial “[The FDA] has been engaged in sustained and ongoing discussions with Gilead Sciences regarding making remdesivir available to patients as quickly as possible, as appropriate,” the US National Institute of Allergy and Infectious Diseases (NIAID) said. The news comes after a mixed bag of announcements on the effects of the drug, which has not been approved anywhere yet and has not been demonstrated to be safe or effective in coronavirus cases. Gilead said on Wednesday that late-stage trials on hospitalised patients revealed that those receiving a ten-day course of remdesivir achieved similar improvement compared with those being treated for five days. However, a study on Chinese patients published in The Lancet on the same day showed that the drug was not bringing significant clinical benefits, though patients taking it were recovering faster than those on a placebo. That’s what the NIAID confirmed in a separate trial, also announced on Wednesday, although more details are yet to be published. Shares in Gilead advanced 3% to US$85.30 in premarket trading.
0
shares
ShareTweetSavePostSend
 
Video Credit: The Street - Published
News video: Gilead Announces Positive Remdesivir Data in U.S. Coronavirus Treatment Study

Gilead Announces Positive Remdesivir Data in U.S. Coronavirus Treatment Study 01:20

Here's the latest on remdesivir.

You Might Like


Related videos from verified sources

Treatment For Coronavirus? Remdesivir Was Tested In Colorado [Video]

Treatment For Coronavirus? Remdesivir Was Tested In Colorado

The FDA is set to approve a treatment for coronavirus. It's a drug that was being tested right here in Colorado.

Credit: CBS 4 Denver     Duration: 02:54Published
Remdesivir trial shows it is an effective treatment [Video]

Remdesivir trial shows it is an effective treatment

The first results of the experimental drug - remdesivir - shows that it has the ability to speed up recovery from coronavirus by 31%. Scientists say this is an important proof of concept that a drug..

Credit: KTNV Channel 13 Las Vegas     Duration: 00:38Published
Coronavirus: Remdesivir antiviral drug reduces recovery time from COVID-19, says study [Video]

Coronavirus: Remdesivir antiviral drug reduces recovery time from COVID-19, says study

Coronavirus: Remdesivir antiviral drug reduces recovery time from COVID-19, says study

Credit: Euronews English     Duration: 01:44Published

Related news from verified sources

Gilead Sciences posts positive data on coronavirus treatment trial

Gilead Sciences Inc (NASDAQ:GILD) has posted positive data on the use of its antiviral agent remdesivir for severe coronavirus (Covid-19) patients. The US pharma...
Proactive Investors

Gilead Sciences reports positive drug results for remdesivir as coronavirus treatment

Gilead Sciences on Wednesday reported potentially encouraging results from a trial for a drug that's being tested as a treatment for the coronavirus.
USATODAY.com

A coronavirus drug seems to work. What’s next?

News that an experimental drug seems to be the first effective treatment for the new coronavirus has unleashed a flurry of interest from doctors and patients —...
Seattle Times Also reported by •Proactive Investors

Tweets about this